l e t t e r s
To identify susceptibility loci for visceral leishmaniasis, we undertook genome-wide association studies in two populations: 989 cases and 1,089 controls from India and 357 cases in 308 Brazilian families (1,970 individuals). The HLA-DRB1-HLA-DQA1 locus was the only region to show strong evidence of association in both populations. Replication at this region was undertaken in a second Indian population comprising 941 cases and 990 controls, and combined analysis across the three cohorts for rs9271858 at this locus showed P combined = 2.76 × 10 −17 and odds ratio (OR) = 1.41, 95% confidence interval (CI) = 1.30-1.52. A conditional analysis provided evidence for multiple associations within the HLA-DRB1-HLA-DQA1 region, and a model in which risk differed between three groups of haplotypes better explained the signal and was significant in the Indian discovery and replication cohorts. In conclusion, the HLA-DRB1-HLA-DQA1 HLA class II region contributes to visceral leishmaniasis susceptibility in India and Brazil, suggesting shared genetic risk factors for visceral leishmaniasis that cross the epidemiological divides of geography and parasite species.
Leishmania are protozoan parasites that live in macrophages. They are transmitted by sand flies and cause severe and debilitating cutaneous as well as fatal visceral disease in subtropical and tropical regions worldwide. Leishmaniasis is classified by the World Health Organization (WHO) as a neglected tropical disease. It affects 12 million people, and there are an estimated 1.5 million new cases annually 1 . Of these, 500,000 are cases of potentially fatal visceral leishmaniasis caused by the Leishmania donovani complex, 90% of which occur in three foci in India-Bangladesh-Nepal, Sudan and Brazil. Skin tests and lymphocyte response analyses indicate that only 1 in 5-10 infected individuals develop clinical disease [2] [3] [4] . The importance of host genetic factors is indicated by familial clustering of clinical disease 5 and high sibling risk ratios 6 . However, human genetic studies undertaken to date (reviewed in refs. 7-9) provide inconsistent results. As part of the Wellcome Trust Case Control Consortium 2 (WTCCC2) study of 15 complex disorders and traits, we report the first genome-wide association study (GWAS) of visceral leishmaniasis across major foci of disease caused by L. donovani in India and Leishmania infantum chagasi in Brazil.
Subjects for the India discovery GWAS (Online Methods and Supplementary Table 1 ) were recruited from Bihar state in northeast India. Affected individuals and controls were matched by selfreported age, sex, religion, caste and geographic region of recruitment. The Brazilian family-based sample was collected as part of the Belém Family Study and from study sites near Natal 6,10,11 (Online Methods and Supplementary Table 1 ).
All individuals were genotyped at the Wellcome Trust Sanger Institute on the custom Illumina Human660W-Quad chip (Online Methods). After performing stringent quality control procedures 12 (Online Methods), the Indian discovery data set comprised 2,078 individuals (989 cases and 1,089 controls) genotyped at 526,731 SNPs, and the Brazilian discovery data set included a total of 1,970 individuals (357 cases from 308 families) genotyped at 553,323 SNPs.
As ancestry differences and close relationships between case and control individuals can confound association studies, we used a variance components method (sometimes referred to as a mixed model), which models the pairwise relatedness between individuals to account for population structure in the data 13 . This approach accounts for relatedness on different scales, from close relatives to distant ancestral structure, and it could thus be applied to both the case-control samples in India and the family data from Brazil. Similar models have recently been used in several other association studies [14] [15] [16] [17] [18] . An advantage of our implementation of the mixed model is that we are able to estimate effect sizes on the log-odds scale. Using this method, the genomic inflation factor (λ) was 1.03 for the Indian analysis and 1.02 for the Brazilian analysis, showing that it successfully handled any population structure or relatedness in the data. The mixed-model approach was used for all analyses presented here, for both discovery and replication data and in further dissection of association signals.
Previous studies attempting to identify the genetic components of visceral leishmaniasis susceptibility have typically been small, underpowered family studies or candidate gene studies [19] [20] [21] [22] [23] . We present the results from our discovery GWAS and replication data at these previously identified loci ( Table 1) . None of the loci previously found Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis l e t t e r s to be associated with visceral leishmaniasis consistently showed an association with visceral leishmaniasis in our three data sets.
Because different pathogen species are responsible for disease in India and Brazil, we first examined each GWAS separately. Our primary focus was on regions showing association in both GWAS analyses. This would be appropriate if similar host genetic factors affected susceptibility to the two different parasite species. Observing the same association in different populations with different study design (population-based and family-based association, respectively) also adds to the robustness of the potential findings.
We combined the Indian and Brazilian GWAS through a fixedeffects meta-analysis ( Fig. 1c) . Two regions had association at P combined < 1 × 10 −6 , one of which was the HLA-DRB1-HLA-DQA1 human leukocyte antigen (HLA) class II region (Supplementary Table 2 ). Details of the regions showing association (P < 1 × 10 −5 ) in only one of the two studies are shown ( Fig. 1 and Supplementary  Tables 3 and 4 ). Apart from the major histocompatibility complex (MHC) region, none of the regions associated at P < 1 × 10 −5 in the separate Indian or Brazilian analyses showed significant association in the combined analysis.
A second Indian cohort was used in a replication analysis of the findings from the two discovery GWAS. These samples were genotyped on the Immunochip 24 , a purpose-designed Illumina chip, some content of which was chosen by WTCCC2 for deep replication of its GWAS findings. After quality control (Online Methods), the Indian replication data set comprised 1,931 individuals (941 visceral leishmaniasis cases and 990 controls). Outside of the MHC region, none of the regions that were associated at P < 1 × 10 −5 in either the separate Indian or Brazilian GWAS or the combined discovery meta-analysis replicated at P < 0.1 in the Indian replication data ( Supplementary  Tables 3 and 4 ). However, only four of the regions associated in the Brazilian GWAS were available on the Immunochip.
The MHC region was the only region that replicated in all three cohorts (rs9271858, P combined = 2.76 × 10 −17 and OR (95% CI) = 1.41 (1.30-1.52)). Notably, although there was shared signal at the MHC in both discovery GWAS, which clearly replicated, there were also differences between the Indian and Brazilian results ( Fig. 2 and Supplementary Table 2 ).
In the Indian discovery GWAS, the two SNPs most associated with visceral leishmaniasis in the MHC region were in strong linkage disequilibrium (LD) (rs9271842 and rs9271858; r 2 = 1 in Indian controls). Only one of these SNPs was present in the replication data (rs9271858); therefore, for convenience, we focused on this SNP and refer to it as the top SNP. This SNP also showed significant association in the Brazilian data (P Brazil = 2.04 × 10 −4 ), but, conversely, the top MHC signal in the Brazilian data (rs9268878) was not significant in the Indian data (P India = 0.71, P replication = 0.58 at rs4428528; r 2 = 1). The top MHC SNP signal in Brazilian data was 163.6 kb upstream of the signal in the Indian data and is in almost complete linkage equilibrium with the top Indian SNP (r 2 = 0.06 in the Brazilian founders). Further replication in a Brazilian data set is required to assess this additional MHC signal: it could be a population-or parasite species-specific association or, alternatively, a false positive finding.
In the Indian discovery cohort, when conditioning on the top SNP from the Indian discovery GWAS (rs9271858), there was still residual association signal in the MHC region; two highly correlated SNPs 19 in which rs4674259 was genotyped as part of a separate Sequenom panel. c r 2 = 1 (HapMap Utah residents of Northern and Western Europe ancestry (CEU)) and 0.71 (HapMap Gujarati Indians in Houston, Texas (GIH)) with previously reported rs3138060.
npg l e t t e r s both associated at P < 1 × 10 −3 (rs9271252 and rs9271255; r 2 = 1 in Indian controls).
For convenience, because one of these SNPs was typed in the discovery and replication samples, we focused on that SNP, rs9271255, which showed an association P value of 8.79 × 10 −4 in the conditional analysis. This SNP was not highly correlated with rs9271858 (r 2 = 0.21 in Indian controls). When conditioning on both rs9271858 and rs9271255, no association signal remained at P < 1 × 10 −3 . In the Indian replication data, when conditioning on rs9271858, the association at rs9271255 was still significant (P = 5.72 × 10 −3 ). This conditional analysis was repeated in the Brazilian discovery data: when conditioning on rs9271858, the association of rs9271255 was significant with a P value of 1.91 × 10 −5 .
We then turned to a more detailed examination of the replicated MHC signal (at rs9271858 and rs9271255). We focused on the Indian data, for which the Indian replication cohort was from a comparable population and could therefore be used to replicate cohort-specific association signals. To further explore the MHC signal in Indian cases, we estimated phase for the SNP genotypes for all individuals in the Indian discovery group. We subsequently fitted a model to the phased haplotypes, with different risk parameters for the four haplotypes defined by the phased genotypes at the two aforementioned SNPs, rs9271858 and rs9271255. After additional exploration of the model (Supplementary Note), we found that combining two of the four haplotypes to give a model with three risk classes fitted the data as well as the model with four risk classes (Supplementary Fig. 1 ) and also gave a better fit than the two-SNP model (Supplementary Note). l e t t e r s At rs9271858 and rs9271255, respectively, the haplotype with the highest risk was defined by the alleles GA, and the haplotype with intermediate risk was define by AA alleles, with the haplotypes AG and GG being protective relative to the other two haplotypes and having statistically indistinguishable risks from them. This model with three risk classes had P = 1 × 10 −11 in the Indian discovery data compared to the null model where all haplotype classes had the same risk. When the protective haplotypes were set as the baseline with OR = 1, the intermediate haplotype OR (95% CI) was 1.28 (1.09-1.50), and the highest risk haplotype OR (95% CI) was 1.72 (1.48-2.00). This analysis replicated in the Immunochip data: the model with three risk classes was significant at P = 4.78 × 10 −6 , with the intermediate haplotype OR (95% CI) equal to 1.19 (1.00-1.40) and the highest risk haplotype OR (95% CI) equal to 1.50 (1.27-1.76). In India (n = 3,732), the frequencies of the 2-SNP haplotypes were AA, 0.301; AG, 0.310; GA, 0.372; and GG, 0.017. In Brazil (n = 1,026), the frequencies of the 2-SNP haplotypes were AA, 0.406; AG, 0.097; GA, 0.390; and GG, 0.105.
Our results establish that common polymorphisms in the HLA-DRB1-HLA-DQA1 segment of the MHC region are genetic risk factors for visceral leishmaniasis, and, notably, their effects seem to cross the epidemiological divides of geography and parasite species. For GWAS associations, the top SNPs are not necessarily the causal variants but may be correlated with the functional variants. There are SNPs in the MHC region that are in moderate LD with rs9271858 (r 2 ≈ 0.2) and are located up to 500 kb away (for example, rs408359: r 2 = 0.19 calculated in the Indian controls). This extensive LD is common in the MHC region and makes it particularly difficult to assess possible functional candidates within the region of association 25 .
One possibility is that the association signal could be driven by functional variation in the adjacent highly polymorphic classical HLA class II genes HLA-DRB1 and HLA-DQB1, each of which is a natural immunological candidate. The classical alleles at these loci were genotyped in a subset of individuals in both of the discovery cohorts and were phased (statistically) onto the haplotypes estimated from all the SNP data (Supplementary Note). In this phased data set, chromosomes carrying the protective haplotype at rs9271858 and rs9271255 always carried one of the three classical HLA-DRB1*15, HLA-DRB1*16 and HLA-DRB1*01 alleles, and the reverse also held true ( Fig. 3 and Supplementary Table 5 ). We note that the HLA-DRB1*01 and HLA-DRB1*16 alleles are very rare in the Indian data (Supplementary Table 5 ), meaning that we had limited power to assess their possible roles. This correlation between protective SNP haplotype and classical HLA-DRB1*15, HLA-DRB1*16 and HLA-DRB1*01 alleles was also perfect in the 142 phased Brazilian discovery sample chromosomes (Online Methods), where all of the chromosomes carrying the protective haplotype defined by rs9271858 and rs9271255 also carried one of the HLA-DRB1*15, HLA-DRB1*16 or HLA-DRB1*01 alleles ( Supplementary Fig. 2 and Supplementary  Table 5 ). This lends support to the possibility that the association signal could be driven by classical HLA alleles and emphasizes the biological importance of endogenous processing and presentation of antigen from infected macrophages and dendritic cells to CD4 + T cells that drive the immune response in visceral leishmaniasis 26, 27 . Nevertheless, additional research will be needed to establish whether or not these HLA-DRB1 alleles are themselves functionally involved in protection against visceral leishmaniasis or are merely correlated with an as-yet-uncharacterized functional variant. Further details of the HLA analysis are presented in the Supplementary Note.
Previous studies of HLA associations in human leishmaniasis have provided confusing and often contradictory results, which have been generally compromised by small sample size and lack of power (reviewed in ref. 9). One small study did find protection associated with HLA-DRB1*15 and HLA-DRB1*16 for visceral leishmaniasis caused by Old World L. infantum 28 , the same parasite species that causes visceral leishmaniasis in Brazil 29 . Protection has also been associated with HLA-DR2 (an alternative name for the HLA-DRB1 serogroup that comprises the HLA-DRB1*15 and HLA-DRB1*16 Figure 3 Schematic of the HLA and SNP phased Indian discovery haplotypes in the MHC region. Each row represents an individual haplotype, and the three middle columns show different risk models, with the shading denoting in which class in the model that haplotype falls: column 2 shows the classification of haplotypes solely on the basis of the allele (risk or protective) present at the top SNP, rs9271858; column 3 shows the classification of haplotypes solely on the basis of the allele (risk or protective) present at the top SNP in the conditional analysis, rs9271255; column 4 shows the three risk groups defined by the allele combinations (risk-risk, protective-risk, protective-protective) at SNPs rs9271858 and rs9271255, respectively, that most parsimoniously capture their phaseknown haplotype associations with disease (supplementary Fig. 1 ). The two outside columns show the HLA alleles at HLA-DRB1 and HLA-DQB1, with colors representing the presence of each allele. This analysis used the subset of individuals in the Indian discovery data for whom classical HLA alleles were available, and the plot shows only the 112 haplotypes for which the posterior probability of the estimated phase at both HLA-DRB1 and HLA-DQB1 was >0.9. Note that the haplotype carrying HLA-DRB1*0101 is rare and is not shown in the plot because it did not occur on a haplotype with a successfully phased HLA-DQB1 allele.
npg l e t t e r s alleles) in small studies of cutaneous and mucocutaneous forms of leishmaniasis caused by Leishmania mexicana 30 and Leishmania braziliensis 31, 32 , respectively. There have been relatively few successful GWAS of infectious disease susceptibility [33] [34] [35] [36] . Our GWAS has identified HLA class II region polymorphisms as significant genetic risk factors for visceral leishmaniasis, with the risk associated with the high-risk haplotype being high by GWAS standards: OR (95% CI) estimated from replication data of 1.50 (1.27-1.76). Notably, genetic variation in the MHC region has not been found to be associated with all infectious diseases. Our observations focus attention on determining the precise nature of HLA class II variation in determining visceral leishmaniasis susceptibility and offer the potential to contribute to the development of strategies for disease control.
MeTHOds
Methods and any associated references are available in the online version of the paper.
ONLINe MeTHOds
Samples. Characteristics of the samples are given in Supplementary Table 1 . In India, the discovery and replication sets comprised cases and controls from villages located within a radius of ~100 km from the city of Muzaffarpur, covering the districts of Muzaffarpur, Vaishali, Samastipur, Saran, Sheohar, East Champaran and Sitamarhi in Bihar state in northeast India. Further epidemiological and demographic details relating to the study site are described elsewhere 37 . An annual incidence rate of 2.49 clinical visceral leishmaniasis cases per 1,000 persons has been reported in the region 37 . Leishmania donovani sensu strictu (zymodeme MON-2) was confirmed as the causative agent of visceral leishmaniasis in the study region, in accordance with other reports on clinical isolates from individuals with kala-azar in the state of Bihar [38] [39] [40] [41] . The controls had no history of visceral leishmaniasis or a family history of visceral leishmaniasis among first-, second-or third-degree relatives. Informed written consent in Hindi was obtained from all participating individuals and from the parents of children under 18 years old. Approval for the study was provided by the Ethical Committee of the Institute of Medical Sciences at Banaras Hindu University.
In northeast Brazil, 64 families were collected from 1991-1994 as part of the Belém Family Study 6, 42 . These families were ascertained from medical records of the Fundacão National de Saude in the states of Para, Maranhão and Piaui on the basis of data from the 1983-1985 and 1993-1994 epidemics. A further 244 families were collected from study sites near Natal, where transmission of the parasite is focal and transient, allowing the identification of neighborhoods with ongoing or recent transmission. These families were ascertained from medical records of the Fundacão National de Saude in Rio Grande do Norte. All families were of equivalent socioeconomic status. The causative agent of visceral leishmaniasis was confirmed to be L. infantum chagasi in a subset (~10% over four states) of individuals with visceral leishmaniasis 6 . Further clinical, epidemiological, family structure and demographic information relating to the families is described elsewhere 6, 10, 21, 42, 43 .
Ethical approval for the Belém Family Study was obtained originally from the local ethics committee at the Instituto Evandro Chagas (Belém, Brazil) 6 Individuals from both India and Brazil were classified as affected when they had been diagnosed with clinical visceral leishmaniasis that responded positively to specific anti-leishmanial treatment. Data on subclinical disease or asymptomatic infections were not included. Diagnosis of clinical visceral leishmaniasis was made on the basis of clinical, parasitological (splenic aspirates in India; bone marrow aspirates in Brazil) and serological criteria as described elsewhere 6, 10, 21, 42, [44] [45] [46] .
DNA sample preparation. For Indian samples, non-invasive buccal swabs
were collected, and genomic DNA was prepared in the Cambridge laboratory. For Brazilian samples, blood was collected by venipuncture from all available family members. Genomic DNA was prepared directly from blood in Natal 10 or from Epstein-Barr virus-transformed B cells cultured from fresh or cryopreserved peripheral blood mononuclear cells in Cambridge 21 . Genomic DNA for all cases was shipped to the Wellcome Trust Sanger Institute. Quality was validated using the Sequenom iPLEX assay designed to genotype 4 genderassociated SNPs and 26 SNPs present on the Illumina BeadChips. DNA concentrations were determined using a PicoGreen assay (Invitrogen), and an aliquot of each was assayed by agarose gel electrophoresis. A DNA sample was considered to have passed quality control if the DNA concentration was greater than or equal to 50 ng/µl, the DNA was not degraded, the gender assignment from the iPLEX assay matched that provided in the subject data manifest and genotypes were obtained for at least two-thirds of the SNPs on the iPLEX array.
Genotyping. DNA from the Indian discovery cases and controls and the Brazilian families was genotyped at the Wellcome Trust Sanger Institute on the Illumina Infinium platform using the Human660W-Quad chip, a custom chip designed by WTCCC2 that comprises Human550 SNPs supplemented with 60,000 additional probes that were intended to allow the genotyping of common copy-number variations (CNVs) from the Structural Variation Consortium 47 . Replication genotyping for Indian samples was carried out at the Wellcome Trust Sanger Institute using the Illumina Immunochip, a custom chip designed by WTCCC2 and the Immunochip Consortium that comprises 196,524 SNPs. For both chips, bead intensity data were processed and normalized for each sample in BeadStudio software (Illumina); data for successfully genotyped samples were extracted, and genotypes were called using Illuminus software (Illumina).
Quality controls. SNPs. SNPs were excluded if the Fisher information for the allele frequency was not close to unity (information of <0.98), if the minor allele frequency (MAF) was very low (defined as <0.01%), if missingness was >0.02 or for extreme departures from Hardy-Weinberg equilibrium (HWE P value of <1 × 10 −20 ). After applying these filters in the Indian discovery, 526,731 autosomal SNPs remained for further analysis. For the Brazilian families, these filters left 553,323 autosomal SNPs. Of the 2 discovery cohorts, 521,134 overlapping SNPs passed quality control in both cohorts. Cluster plots of the hit SNPs described in this study are shown in Supplementary Figure 3 .
Samples. For quality control of samples typed on the Indian and Brazilian Illumina Human660W-Quad data, a Bayesian clustering method was used to infer and exclude outlying individuals on the basis of call rate, heterozygosity and signal intensity 12, 48 . To remove signal intensity outliers observed in raw intensity data, the difference between the A channel intensity and the B channel intensity was averaged over all SNPs on autosomes for each sample. A similar approach was used in which the intensity measures from the A channel on the non-pseudoautosomal X chromosomes was used to identify outliers and infer gender for all Indian and Brazilian samples. Samples were removed if inferred gender was discordant with the recorded gender after crosschecking with original database entries or if less than 90% of the SNPs typed by Sequenom on entry to sample handing agreed with the genome-wide data. Duplicated individuals were also excluded. For the Indian discovery sample, a total of 121 of 2,199 individuals were removed following these quality control checks. For the Indian replication sample, 111 of 2,042 individuals were removed. For the Brazilian family study, additional quality control tests were carried out to verify (and, if necessary, adjust) the expected pedigree relationships between the individuals. Genome-wide identity-by-descent (IBD) sharing probabilities for all pairs of individuals were estimated using a subset of 11,177 autosomal markers with PLINK software 49 . These estimates were used to assist in pedigree validation and resulted in 49 additional individuals being removed after quality control owing to unresolved pedigree relationship discrepancies. In total, for the Brazilian family study, 189 of 2,159 individuals were removed.
Statistical analyses. We carried out association analyses using a novel 13 variance components method (a linear mixed model, similar to that described by Kang et al. 17 ). The linear mixed model explicitly accounts for correlations in individuals' phenotypes due to their relatedness through specification of the phenotypic variance-covariance matrix in terms of parameters representing underlying genetic and environmental components of variance (estimated during the model fitting procedure) and pairwise relatedness measures (kinship coefficients; estimated before model fitting on the basis of the genome-wide genotype data). In this analysis, we used a standard linear mixed model y = Xβ + Q + ε, where y = (y 1 , y 2 …, y n ) T is a vector of responses (coded 1/0 for case/control) on n subjects, X = (x ik ) is the n × K matrix of predictor values for any variable to be modeled as fixed effects (including variables representing covariates and genotypes at any SNP currently under test), β = (β 1 , β 2 …, β K ) T are regression coefficients (to be estimated) representing the linear effects of the predictors on the response and Q and ε are random effects assigned the distributions Q N g ∼ ( ) parameters (to be estimated) representing the genetic and environmental components of variance, respectively, I is the n × n identity matrix and Φ is the n × n matrix of pairwise kinship coefficients.
npg Although use of this linear mixed model was originally proposed for pedigrees with known relationships [50] [51] [52] [53] , recently this approach has gained popularity for use with samples of unknown or uncertain relationship 13, 17, 18, 54 , including seemingly unrelated samples that may nevertheless show distant levels of common ancestry. For this purpose, the pairwise kinship coefficients modeling either close or distant relatedness are estimated (before fitting the linear mixed model) on the basis of genome-wide genotype data instead of being fixed at known theoretical values.
Computational considerations have led to the development of several faster approximations for constructing tests of the fixed effects of interest in the linear mixed model [15] [16] [17] 53, 55, 56 . These approximate tests have been implemented in various software packages, including EMMAX, TASSEL, FaST-LMM and GenABEL. For the analyses presented here, we used our own implementation of the linear mixed model, developed for a previous study 13 , which has the advantage, in common with the recently developed GEMMA package 57 , of fitting the full (rather than an approximate) model, which in principle can lead to a small increase in power, depending on the underlying true model. Our implementation also allows a transformation between the parameters of the linear model described above and the logistic model (which is the usual model for case-control data), allowing the convenient estimation of effects on the log-odds scale and the generation of resulting OR estimates. We confirmed that the Indian discovery results did not change significantly after the inclusion of the first ten principal components in the linear mixed model (data not shown).
Combined P values across Indian (discovery and replication) and Brazilian data sets were calculated in R using an inverse-variance fixed-effects meta-analysis.
In addition, for the Brazilian family study, we verified our results using two complementary alternative methods implemented in the software packages FBAT 58 and ROADTRIPS 59 . Results were comparable across the different methods (data not shown).
HLA typing. The HLA-DRB1 and HLA-DQB1 typing of 100 selected Indian discovery individuals was performed using a sequencing-based method 60 . To select these individuals, SNPs in the class II region HLA-DRA-HLA-DQB2 locus (32,514,320-32,840,188 bp on chromosome 6 of NCBI Build 36) were first pruned in PLINK 49 to generate a set of 78 SNPs in approximate linkage equilibrium (r 2 < 0.8) and with MAF > 0.1. LD blocks across these 78 SNPs were then visualized using Haploview 61 , and the top 59 haplotype-tagging SNPs were selected and used to generate haplotypes for all 1,866 unrelated individuals in fastPHASE 62 . The subset of 100 individuals selected for sequence-based HLA typing represented the 135 most common 59-SNP haplotypes in the region. Automated sequencing was carried out on ABI Prism 3730 or 3730xl Genetic Analyzers (Applied Biosystems), and HLA-DRB1 analysis was carried out using ASSIGNV4.0.1.36 (Conexio Genomics). Where possible, individuals were assigned HLA-DRB1 or HLA-DQB1 specificities to the four-digit level 63 , that is, to a specific HLA protein encoded on each chromosome (for example, HLA-DRB1*1501, where HLA-DRB1*1501 is a specific functional HLA-DRB1 protein). Where this was not possible, individuals were assigned to a two-digit allele group; for example, HLA-DRB1*15 indicates an allele group in which all specific functional HLA-DRB1 proteins share common ancestry.
HLA-DRB1 and HLA-DQB1 typing was further performed in a subset of 71 unrelated individuals from the Brazilian families using the same sequencebased method as was used for the Indian samples.
Phasing the SNP and HLA data. SNPs in the MHC region and HLA-DRB1 and HLA-DQB1 alleles were phased using IMPUTE2 (ref. 64 ) and PHASE 65 . The Indian discovery and Brazilian replication cohorts were treated separately throughout the phasing pipeline.
For the Indian discovery data, IMPUTE2 (ref. 64 ) was used to phase all the SNPs on chromosome 6 for 1,866 individuals, using HapMap 3 populations as the haploid reference panel. For the Brazilian data, 5,667 SNPs in the MHC region (20, 733, 984 ,313 bp) were phased. The phasing of the Brazilian data was performed in two stages, first with an unrelated set of 498 parents and second with an unrelated set of 268 offspring, totaling 766 individuals. The parent-child trio relationships were then used to examine the accuracy of both SNP and HLA allele phasing.
Treating the IMPUTE2 SNP phasing as fixed, PHASE 65 was then used to phase the HLA alleles typed at HLA-DRB1 and HLA-DQB1 onto SNP haplotypes in the HLA region, selecting only haplotypes phased at a probability of >0.9. PHASE 65 was used to phase the multiallelic HLA-DRB1 and HLA-DQB1 alleles onto the known SNP haplotypes, specifying known phase at all of the SNPs and the PHASE options −MR and -d1. The HLA alleles were given positions: HLA-DRB1 was set at 32,597,662 bp, between rs28756238 and rs41546317, and HLA-DQB1 was set at 32,735,635 bp between rs28724231 and rs1063355. Both HLA-DRB1 and HLA-DQB1 alleles were phased in the Indian data, and HLA-DRB1 was phased in the Brazilian data.
After quality control of the PHASE data, in the Indian discovery set, there was a total of 3,732 SNP haplotypes, 154 with HLA-DRB1 alleles and 153 with HLA-DQB1 alleles. Of these, 112 were phased to the 4-digit level for both HLA-DRB1 and HLA-DQB1. In the Brazilian data set, there was a total of 1,481 SNP haplotypes, 142 of which were phased with 2-digit HLA-DRB1 alleles.
Haplotype analyses. Haplotype associations were investigated by applying two methods: a conditional analysis and a Bayesian approach. Both methods gave the same result, with each fitting a three-haplotype model of risk.
GENECLUSTER, which adopts a Bayesian approach 66 , was used to look for primary and secondary association signals at known and putative SNPs. This method analyzes the genealogy of the case-control sample to find evidence for causal mutation(s). It uses the genealogy of a reference haplotype panel (in this case, HapMap 3 GIH haplotypes) to approximate the genealogy of the case-control sample at positions across the region by clustering the case-control haplotypes under the leaves of the reference genealogy. Placing a disease-associated mutation on a branch of the reference genealogy segregates the haplotypes at the leaves into two different risk groups: those case-control haplotypes that fall under the disease-associated mutation (and therefore carry the mutation) and those that do not. For a given mutation in the tree, GENECLUSTER carries out a Bayesian test of association. The model can also be extended to two disease mutations in the genealogy. For these data, the genealogical tree was estimated on chromosome 6 at 32,678,817 bp. The log 10 (Bayes factor) for the 2-mutation (3-haplotype) model was 7.36 compared to a log 10 (Bayes factor) of 5.42 for a single-mutation (2-haplotype) model.
After the linear mixed-model conditional analysis, we phased the SNP data for all individuals in the India discovery data and found that the two SNPs associated in the conditional analysis (rs9271858 and rs9271255) tagged the haplotypes from the GENECLUSTER analysis. The first mutation perfectly correlated with the protective haplotype, and the second mutation separated the risk halotype into two groups, which are well tagged by the two SNP intermediate and risk haplotypes (r 2 protective = 1, intermediate = 0.49, risk = 0.60; overall correlation of 0.86).
